These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 36341437)

  • 41. Cuproptosis-related genes score and its hub gene GCSH: A novel predictor for cholangiocarcinomas prognosis based on RNA seq and experimental analyses.
    He R; Li Y; Jiao P; Huang Y; Dong S; Mo L; Jiao X
    J Cancer; 2024; 15(6):1551-1567. PubMed ID: 38370386
    [No Abstract]   [Full Text] [Related]  

  • 42. Identification of Cuproptosis-Related Subtypes, Establishment of a Prognostic Signature and Characterization of the Tumor Microenvironment in Gastric Cancer.
    Li J; Kong C; Song W; Fu T
    Int J Gen Med; 2023; 16():1631-1652. PubMed ID: 37168531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma.
    Sun Y; Lei S; Luo X; Jiang C; Li Z
    Front Pharmacol; 2023; 14():1129544. PubMed ID: 37138850
    [No Abstract]   [Full Text] [Related]  

  • 44. Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma.
    Ding L; Li W; Tu J; Cao Z; Li J; Cao H; Liang J; Liang Y; Yu Q; Li G
    Front Immunol; 2022; 13():989156. PubMed ID: 36177029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of a cuproptosis-related prognostic signature in colon cancer tumor microenvironment and immune responses.
    Xu C; Liu Y; Zhang Y; Gao L
    Front Genet; 2022; 13():928105. PubMed ID: 36313449
    [No Abstract]   [Full Text] [Related]  

  • 46. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
    Song S; Zhang M; Xie P; Wang S; Wang Y
    Front Immunol; 2022; 13():978909. PubMed ID: 36341328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identifying novel circadian rhythm biomarkers for diagnosis and prognosis of melanoma by an integrated bioinformatics and machine learning approach.
    Xu Y; Zeng C; Bin J; Tang H; Li W
    Aging (Albany NY); 2024 Jun; 16(16):11824-11842. PubMed ID: 39213172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of cuproptosis-related subtypes, establishment of a prognostic model and tumor immune landscape in endometrial carcinoma.
    Shan J; Geng R; Zhang Y; Wei J; Liu J; Bai J
    Comput Biol Med; 2022 Oct; 149():105988. PubMed ID: 36007289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pan-cancer analysis of cuproptosis regulation patterns and identification of mTOR-target responder in clear cell renal cell carcinoma.
    Long S; Wang Y; Chen Y; Fang T; Yao Y; Fu K
    Biol Direct; 2022 Oct; 17(1):28. PubMed ID: 36209249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of immune infiltration and cuproptosis-related molecular clusters in tuberculosis.
    Li S; Long Q; Nong L; Zheng Y; Meng X; Zhu Q
    Front Immunol; 2023; 14():1205741. PubMed ID: 37497230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
    Pan Y; Zhang Q; Zhang H; Kong F
    Funct Integr Genomics; 2023 Jan; 23(1):38. PubMed ID: 36640225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma.
    Cheng X; Zeng Z; Yang H; Chen Y; Liu Y; Zhou X; Zhang C; Wang G
    BMC Cancer; 2023 Jan; 23(1):105. PubMed ID: 36717792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma.
    Li Y; Zeng X
    Front Pharmacol; 2022; 13():1081952. PubMed ID: 36703728
    [No Abstract]   [Full Text] [Related]  

  • 54. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
    Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular Subtypes Defined by Cuproptosis-Associated Genes, Prognostic Model Development, and Tumor Immune Microenvironment Characterization in Adrenocortical Carcinoma.
    Huang Q; Huang XY; Xue YT; Wu XH; Wu YP; Ke ZB; Kang Z; Xu YC; Chen DN; Wei Y; Xue XY; Huang ZY; Xu N
    J Inflamm Res; 2024; 17():7017-7036. PubMed ID: 39377045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning.
    Bai Z; Lu J; Chen A; Zheng X; Wu M; Tan Z; Xie J
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer.
    Wang X; Zuo X; Hu X; Liu Y; Wang Z; Chan S; Sun R; Han Q; Yu Z; Wang M; Zhang H; Chen W
    Front Oncol; 2023; 13():927608. PubMed ID: 37007145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases.
    Ma Q; Hui Y; Huang BR; Yang BF; Li JX; Fan TT; Gao XC; Ma DY; Chen WF; Pei ZX
    Transl Cancer Res; 2023 Jan; 12(1):46-64. PubMed ID: 36760376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Machine learning-based solution reveals cuproptosis features in inflammatory bowel disease.
    Liu L; Liang L; Yang C; Chen Y
    Front Immunol; 2023; 14():1136991. PubMed ID: 37275904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cuproptosis-Related genes in the prognosis of colorectal cancer and their correlation with the tumor microenvironment.
    Wu W; Dong J; Lv Y; Chang D
    Front Genet; 2022; 13():984158. PubMed ID: 36246586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.